Pfizer posts strong Q2 earnings and raises EPS outlook, with oncology growth and new drugs offsetting looming headwinds.

Royalty Pharma Plc (NASDAQ:RPRX) is one of the top most undervalued biotech stocks to buy now. In a report released on August ...

Novo Nordisk's FY 2025 guidance cuts are driven by softer U.S. Wegovy/Ozempic and GLP-1 trends. Click here to find out why I ...

The outlook for the gastric cancer treatment market appears favorable, fueled by progress in targeted therapies and immunotherapies. Traditionally, p ...

Pfizer (PFE) stock and BioNTech (BNTX) stock in focus as FDA may not renew the authorization for their pediatric COVID shot. Read more here.

Pfizer (NYSE:PFE) and Astellas Pharma (OTCPK:ALPMF) announced on Tuesday that their jointly developed antibody-drug conjugate ...

Indian equity benchmarks closed lower in a volatile Tuesday session, weighed down by blue-chip bank stocks and caution ahead ...

Pfizer Inc. reported groundbreaking results in its recent Phase 3 study. **The study showcased HYMPAVZI, reducing bleeding rates by 93% compared to traditional treatments.** This once-weekly ...

Blackstone shares rose 0.69% on impressive Q2 results.** Revenue soared 43% reaching $3.8 billion, while net income jumped 72 ...